VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Aug 8, 2007 -- Tekmira Pharmaceuticals Corporation ("Tekmira") (Toronto:TKM.TO - News) reported today in its Second Quarter 2007 operating results that it remains on track to complete all its 2007 drug development milestones and expects to have eight treatments for cancer and other diseases in human clinical trials in the next 12 to 18 months.
